These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15692268)

  • 21. Polychromatic flow cytometry identifies novel subsets of circulating cells with angiogenic potential in pediatric solid tumors.
    Pradhan KR; Mund JA; Johnson C; Vik TA; Ingram DA; Case J
    Cytometry B Clin Cytom; 2011 Sep; 80(5):335-8. PubMed ID: 21567939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
    Ferrara N; Hillan KJ; Novotny W
    Biochem Biophys Res Commun; 2005 Jul; 333(2):328-35. PubMed ID: 15961063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. May the remodeling of the Ca²⁺ toolkit in endothelial progenitor cells derived from cancer patients suggest alternative targets for anti-angiogenic treatment?
    Moccia F; Poletto V
    Biochim Biophys Acta; 2015 Sep; 1853(9):1958-73. PubMed ID: 25447551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bevacizumab (Avastin) inhibits lung cancer-induced pulmonary microvascular angiogenesis].
    Liu JX; Wang XG; Fu J; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1027-9, 1043. PubMed ID: 16864105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms regulating the angiogenic phenotype in tumors: clinical impact in the future.
    Aubry K; Barriere G; Chable-Rabinovitch H; Dutour A; Paraf F; Monteil J; Rigaud M
    Anticancer Res; 2007; 27(5A):3111-9. PubMed ID: 17970051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis.
    Fürstenberger G; von Moos R; Senn HJ; Boneberg EM
    Br J Cancer; 2005 Oct; 93(7):793-8. PubMed ID: 16160694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of tumor endothelial cells and drug delivery.
    Hida K; Maishi N; Sakurai Y; Hida Y; Harashima H
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):140-147. PubMed ID: 26626622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of endothelial progenitor cells in cancer progression.
    Moschetta M; Mishima Y; Sahin I; Manier S; Glavey S; Vacca A; Roccaro AM; Ghobrial IM
    Biochim Biophys Acta; 2014 Aug; 1846(1):26-39. PubMed ID: 24709008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.
    Dome B; Timar J; Dobos J; Meszaros L; Raso E; Paku S; Kenessey I; Ostoros G; Magyar M; Ladanyi A; Bogos K; Tovari J
    Cancer Res; 2006 Jul; 66(14):7341-7. PubMed ID: 16849585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy.
    Dome B; Timar J; Ladanyi A; Paku S; Renyi-Vamos F; Klepetko W; Lang G; Dome P; Bogos K; Tovari J
    Crit Rev Oncol Hematol; 2009 Feb; 69(2):108-24. PubMed ID: 18768327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and cellular biomarkers for angiogenesis in clinical oncology.
    Bertolini F; Mancuso P; Shaked Y; Kerbel RS
    Drug Discov Today; 2007 Oct; 12(19-20):806-12. PubMed ID: 17933680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelets and cancer angiogenesis nexus.
    Wojtukiewicz MZ; Sierko E; Hempel D; Tucker SC; Honn KV
    Cancer Metastasis Rev; 2017 Jun; 36(2):249-262. PubMed ID: 28681240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multifaceted circulating endothelial cell in cancer: towards marker and target identification.
    Bertolini F; Shaked Y; Mancuso P; Kerbel RS
    Nat Rev Cancer; 2006 Nov; 6(11):835-45. PubMed ID: 17036040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-angiogenic cytokines and their role in tumor angiogenesis.
    Neufeld G; Kessler O
    Cancer Metastasis Rev; 2006 Sep; 25(3):373-85. PubMed ID: 17006765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.
    Lopes FC; Traina F; Almeida CB; Leonardo FC; Franco-Penteado CF; Garrido VT; Colella MP; Soares R; Olalla-Saad ST; Costa FF; Conran N
    Haematologica; 2015 Jun; 100(6):730-9. PubMed ID: 25769545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
    Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
    Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of angiogenesis in the pathogenesis of cancer.
    Hoff PM; Machado KK
    Cancer Treat Rev; 2012 Nov; 38(7):825-33. PubMed ID: 22677191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endothelial cells in tumor microenvironment.
    Yang D; Guo P; He T; Powell CA
    Clin Transl Med; 2021 Jun; 11(6):e450. PubMed ID: 34185401
    [No Abstract]   [Full Text] [Related]  

  • 40. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
    Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.